loader
Please Wait
Applying Filters...
menu
    • menu

    Annual Sales of Laninamivir reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

    Client Email Product
    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    Laninamivir

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Inavir

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Inavir

    Laninamivir

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Inavir

    Japan
    arrow
    Formnext Forum
    Not Confirmed

    Daiichi Sankyo

    Laninamivir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 91

    2019 Revenue in Millions : 231

    Growth (%) : -61

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Inavir

    Laninamivir

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Inavir

    Japan
    arrow
    Formnext Forum
    Not Confirmed

    Daiichi Sankyo

    Laninamivir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 20

    2020 Revenue in Millions : 90

    Growth (%) : -76

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Inavir

    Laninamivir

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Inavir

    Japan
    arrow
    Formnext Forum
    Not Confirmed

    Daiichi Sankyo

    Laninamivir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2019 Revenue in Millions : 234

    2018 Revenue in Millions : 191

    Growth (%) : 23

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF